Php23 a Comparative Analysis of the Financing, Pricing and Reimbursement Systems for Prescription Drugs in the Nordic Countries

A comparative analysis of coverage decisions for outpatient pharmaceuticals: Evidence from Denmark, Norway and Sweden

“…The present study adds to previous studies reviewing HTA processes and reimbursement decisions in individual countries and across countries [3][4][5][6] and to studies comparing drug reimbursement systems in Scandinavia [7,8]. HTA methodologies have been implemented in many ways across OECD countries.…”